Jaguar Health, Inc. is a commercial-stage pharmaceuticals company focused on developing novel proprietary prescription medicines derived from rainforest plants for gastrointestinal distress in people and animals. Its flagship product, Mytesi (crofelemer 125 mg delayed-release tablets), is FDA-approved for noninfectious diarrhea in HIV/AIDS patients on antiretroviral therapy. The company also develops Canalevia-CA1 for chemotherapy-induced diarrhea in dogs, and is pursuing crofelemer for cancer therapy-related diarrhea, IBS-D, and rare/orphan diseases through subsidiaries Napo Pharmaceuticals and Napo Therapeutics.
expected 2026-12-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-03-31 | 2024-12-31 | 0000950170-25-047184 | EDGAR | 105K words |
| 2024-04-01 | 2023-12-31 | 0001558370-24-004439 | EDGAR | 94K words |
| 2023-03-24 | 2022-12-31 | 0001558370-23-004572 | EDGAR | — |
| 2022-03-11 | 2021-12-31 | 0001558370-22-003435 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001558370-21-003811 | EDGAR | — |
| 2020-04-03 | 2019-12-31 | 0001558370-20-003581 | EDGAR | — |
| 2019-04-10 | 2018-12-31 | 0001558370-19-002908 | EDGAR | — |
| 2018-04-09 | 2017-12-31 | 0001047469-18-002654 | EDGAR | — |
| 2017-02-15 | 2016-12-31 | 0001047469-17-000684 | EDGAR | — |
| 2016-03-29 | 2015-12-31 | 0001047469-16-011700 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-19 | 2026-06-30 | 0001193125-26-356570 | EDGAR | 75K words |
| 2025-11-14 | 2025-09-30 | 0001193125-25-282950 | EDGAR | 58K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-108393 | EDGAR | 57K words |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072367 | EDGAR | 49K words |
| 2024-11-13 | 2024-09-30 | 0000950170-24-125916 | EDGAR | 54K words |
| 2024-08-13 | 2024-06-30 | 0001558370-24-011971 | EDGAR | 48K words |
| 2024-05-14 | 2024-03-31 | 0001558370-24-008050 | EDGAR | 41K words |
| 2023-11-14 | 2023-09-30 | 0001558370-23-018909 | EDGAR | 44K words |
| 2023-08-14 | 2023-06-30 | 0001558370-23-014683 | EDGAR | 41K words |
| 2023-05-15 | 2023-03-31 | 0001558370-23-009695 | EDGAR | 34K words |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017547 | EDGAR | — |
| 2022-08-22 | 2022-06-30 | 0001558370-22-013831 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-28 | 0001193125-26-403356 | EDGAR | — |
| 2026-09-25 | 0001193125-26-401239 | EDGAR | 1K words |
| 2026-09-24 | 0001193125-26-400087 | EDGAR | 1K words |
| 2026-09-21 | 0001193125-26-396752 | EDGAR | 1K words |
| 2026-09-15 | 0001193125-26-391682 | EDGAR | 9K words |
| 2026-09-15 | 0001193125-26-391415 | EDGAR | 1K words |
| 2026-09-04 | 0001193125-26-383673 | EDGAR | 1K words |
| 2026-08-19 | 0001193125-26-356915 | EDGAR | 3K words |
| 2026-07-14 | 0001193125-26-303190 | EDGAR | 15K words |
| 2026-03-09 | 0001193125-26-097700 | EDGAR | 5K words |
457 total filings indexed. 425 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001585608 |
| Ticker | JAGX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | San Francisco, California |
| Website | http://www.jaguar.health |
| Listed | 2015-05-13 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/JAGX (~200 tokens, structured JSON with cryptographic provenance)